Topic AstraZeneca

Companies AstraZeneca

News AstraZeneca

• BioFocus and Argenta Announce Drug Discovery Collaboration with AstraZeneca in Respiratory and Inflammatory Disease

  Galapagos’ service companies, BioFocus and Argenta, announced they have entered into a multi-year collaboration agreement with AstraZeneca to find new compounds against key targets of interest to AstraZeneca’s research programs in respiratory and inflammatory diseases. Under the terms of the collabo more

• 'Cancer Drug Market Will Reach $75 Billion in 2012' visiongain Report Predicts

  A new report by visiongain predicts that the world market for cancer-treating drugs will reach $75 billion for 2012. That revenue forecast appears in Leading Anti-Cancer Drugs and Associated Market 2012-2022, published in February 2012. The new study predicts that overall revenues for anti-cancer tr more

• Sanofi Tops Pfizer As Number One For Global Pharma Sales

  EvaluatePharma Ltd revealed that Sanofi is expected to take the top spot amongst the world’s pharmaceuticals manufacturers in 2012 and hold it through 2016. The French drug maker has raced up the rankings over the last decade largely through M&A activity, with the $20bn purchase this year of US biot more

Publications AstraZeneca

• AstraZENeca and the ART of metadata maintenance

  Abstract: The use of metadata to drive dynamic programming is a common and well documented process, from Oracle H system tables to the SAS ® SQL dictionary tables. Analysis and Reporting Technology (A&RT), AstraZeneca's first truly global reporting system, extends this concept to incorporate more

• Pollution: Drug firm monitors waste water

  Pollution: Drug firm monitors waste water Nature 477, 7362 (2011). doi:10.1038/477033c Authors: Jason Snape, Chris Lewis & Richard Murray-Smith At AstraZeneca we are proactively addressing the problem of pharmaceuticals entering the more

• Ticagrelor

  Ticagrelor Nature Reviews Drug Discovery 10, 255 (2011). doi:10.1038/nrd3418 Authors: Kurt Huber, Bashar Hamad & Peter Kirkpatrick Ticagrelor (Brilique; AstraZeneca), an oral antiplatelet therapy, was granted marketing authorization by the European Commission in December 2010 more

Market studies AstraZeneca

• Global Cancer Drug Market 2010-2014

  TechNavio’s analysts forecast the Global Cancer Drug market to grow at a CAGR of 12.6 percent over the period 2010–2014. One of the key factors contributing to this market growth is the increase in the prevalence of cancer worldwide. The Global Cancer Drug market in the Americas, and the EMEA and AP more

• Ovarian Cancer Therapeutics - Global Drug Forecasts and Treatment Analysis 2020

  Introduction GlobalData, the industry analysis specialist, has released its new report, “Ovarian Cancer Therapeutics - Global Drug Forecasts and Treatment Analysis 2020”. The report is an essential source of information and analysis on the global ovarian cancer therapeutics market. The report provi more

• Bile Duct Cancer Therapeutics - Pipeline Assessment and Market Forecasts to 2019

  Introduction GlobalData, the industry analysis specialist, has released its new report, “Bile Duct Cancer Therapeutics - Pipeline Assessment and Market Forecasts to 2019”. The report is an essential source of information and analysis on the global Bile Duct Cancer Therapeutics market. The report id more

Websites AstraZeneca